(1) CryoPatch SG Pulmonary Human Cardiac Hemi-Artery - Artery Patch, SGPH00 Cryopreserved Decellu...

FDA Recall #Z-2532-2024 — Class II — May 28, 2024

Recall #Z-2532-2024 Date: May 28, 2024 Classification: Class II Status: Ongoing

Product Description

(1) CryoPatch SG Pulmonary Human Cardiac Hemi-Artery - Artery Patch, SGPH00 Cryopreserved Decellularized Cardiac Tissue Allograft Prepared with SynerGraft (SG) Technology; and (2) CryoPatch SG Pulmonary Human Cardiac Branch Patch, SGP020, Cryopreserved Decellularized Cardiac Tissue Allograft Prepared with SynerGraft (SG) Technology.

Reason for Recall

Grafts were found to have been approved, released, shipped and implanted with an invalid test results.

Recalling Firm

Artivion, Inc — Kennesaw, GA

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Devices

Product Quantity

2 arteries, 1 patch

Distribution

US Nationwide distribution in the states of CA, DC, FL, and NY.

Code Information

(1) SGPH00 - Serial #12071128, exp. 17Nov2027; and serial #11586249, exp. 04May2025; UDI-DI: 00877234000461. (2) SGP020 - Serial #12658767, exp. 15Aug2028; UDI-DI: 00877234000485.

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated